獣医臨床試験の世界市場レポート 2025年

獣医臨床試験の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.5％で69億7,000万米ドルに成長すると予想されます。予測期間における成長は、ペット飼育数の増加、動物疾病の有病率の増加、高度な獣医学的治療に対する需要の増加、獣医学研究に対する規制支援の増加、コンパニオンアニマルヘルスケアの拡大、動物の慢性疾患の有病率の増加に起因しています。予測期間における主な動向としては、データ解析のためのAIの採用、正確な診断のための高度な画像技術、遠隔モニタリングのためのデジタルプラットフォームの採用、安全なデータ管理のためのブロックチェーン、リアルタイムの健康追跡のためのウェアラブル、カスタマイズされた医療機器のための3Dプリンティング、遠隔診察や試験管理のための遠隔医療などがあります。

獣医臨床試験市場は、ペットを飼う人の増加により成長すると考えられています。ペットの所有には、家族のコンパニオンとして動物を飼い、世話をすることが含まれます。ペット飼育の増加の背景には、交友関係への欲求、ペットセラピーの利点、ペットが心身の健康にどのようなプラスの影響を与えるかについての意識の高まりなどの要因があります。獣医臨床試験は先進的な治療へのアクセスを提供し、獣医療を改善することで、動物の健康状態の改善につながります。これらの臨床試験は、より安全で効果的な治療法の開発にも役立っています。例えば、英国を拠点とする獣医慈善団体The People's Dispensary for Sick Animalsが2024年6月に発表したレポートによると、英国におけるペットの犬の数は、2021年の960万頭から2024年には約1,060万頭に達すると予測しています。このようなペット飼育数の増加が、獣医臨床試験市場の成長を牽引しています。

獣医臨床試験市場の企業は、ペットの長寿と全体的な健康を増進するために、新規抗老化薬の開発に注力しています。新規抗老化薬とは、老化プロセスを遅らせたり、逆行させたりするように設計された革新的な薬であり、それによって高齢動物の健康と活力を向上させます。例えば、2024年2月、米国を拠点とする動物用医薬品会社Loyalは、高齢犬の健康寿命を延ばすことを目的としたLOY-002と呼ばれる新しい抗老化薬の臨床試験を開始しました。このチュアブルタイプの錠剤は、ほとんどの高齢犬（小型犬を除く）を対象としており、米国内の50以上の動物病院から10歳以上の犬1,000頭以上を募集する計画のSTAY研究でテストされています。LOY-002の主な目的は、代謝の健康を改善することであり、加齢に関連する病気を遅らせ、高齢犬の全体的な生活の質を高める可能性があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の獣医臨床試験市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の獣医臨床試験市場：成長率分析
• 世界の獣医臨床試験市場の実績：規模と成長、2019～2024年
• 世界の獣医臨床試験市場の予測：規模と成長、2024～2029年、2034年
• 世界の獣医臨床試験総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の獣医臨床試験市場：動物別、実績と予測、2019～2024年、2024～2029年、2034年
• 家畜
• コンパニオンアニマル
• その他
• 世界の獣医臨床試験市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• 腫瘍学
• 内科
• 整形外科
• 心臓病学
• 神経学
• 眼科
• 皮膚科
• その他
• 世界の獣医臨床試験市場：介入別、実績と予測、2019～2024年、2024～2029年、2034年
• 医薬品
• 医療機器
• その他
• 世界の獣医臨床試験市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 学術研究センター
• 製薬およびバイオ医薬品企業
• その他
• 世界の獣医臨床試験市場：家畜のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 牛
• 羊
• ヤギ
• 豚
• 家禽
• 世界の獣医臨床試験市場：コンパニオンアニマルのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬
• 猫
• 馬
• ウサギ
• フェレット
• 世界の獣医臨床試験市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 野生動物
• エキゾチックペット
• 実験動物
• 水生動物

第7章 地域別・国別分析

• 世界の獣医臨床試験市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の獣医臨床試験市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 獣医臨床試験市場：競合情勢
• 獣医臨床試験市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Charles River Laboratories International Inc.
• IDEXX Laboratories Inc.
• Ceva Sante Animale
• Hill's Pet Nutrition Inc.
• Ethos Veterinary Health LLC
• Orion Corporation
• Dechra Pharmaceuticals plc
• The Schwarzman Animal Medical Center
• Argenta Holdco Limited
• Morris Animal Foundation
• Vaxine Pty Ltd
• Bioagile Therapeutics Pvt. Ltd.
• VetStem Inc.
• VetDC
• Vivesto AB

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 獣医臨床試験市場2029：新たな機会を提供する国
• 獣医臨床試験市場2029：新たな機会を提供するセグメント
• 獣医臨床試験市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Veterinary clinical trials are research studies aimed at evaluating the safety, efficacy, and outcomes of new treatments, medications, or medical devices for animals. These trials follow detailed protocols to determine how effective a therapeutic intervention is in preventing, diagnosing, or treating health conditions in animals.

The primary subjects of veterinary clinical trials include livestock animals, companion animals, and others. Livestock animals are domesticated animals raised for agricultural purposes, such as producing meat, milk, eggs, wool, and other products. This category includes species such as cattle, sheep, pigs, goats, and poultry. Veterinary trials for these animals address various conditions, including oncology, internal medicine, orthopedics, cardiology, neurology, ophthalmology, and dermatology, using treatments such as medicines and medical devices. The end users of these trials encompass academic and research institutions, as well as pharmaceutical and biopharmaceutical companies, among others.

The veterinary clinical trials market research report is one of a series of new reports from The Business Research Company that provides veterinary clinical trials market statistics, including the veterinary clinical trials industry's global market size, regional shares, competitors with a veterinary clinical trials market share, detailed veterinary clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary clinical trials industry. This veterinary clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary clinical trials market size has grown strongly in recent years. It will grow from $4.42 billion in 2024 to $4.85 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to a rise in pet ownership, an increase in demand for animal health products, growth in livestock farming, a rise in regulatory pressure for safe animal treatments, and a growth in focus on zoonotic disease prevention.

The veterinary clinical trials market size is expected to see strong growth in the next few years. It will grow to $6.97 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rising pet ownership, increasing prevalence of animal diseases, growing demand for advanced veterinary treatments, rising regulatory support for veterinary research, expansion of companion animal healthcare, and growing prevalence of chronic diseases in animals. Major trends in the forecast period include the adoption of AI for data analysis, advanced imaging technologies for precise diagnostics, adoption of digital platforms for remote monitoring, blockchain for secure data management, wearables for real-time health tracking, 3D printing for customized medical devices, and telemedicine for remote consultations and trial management.

The veterinary clinical trials market is supposed to grow due to the increasing number of pet owners. Pet ownership involves having and caring for animals as domestic companions. The rise in pet ownership is driven by factors such as the desire for companionship, the benefits of pet therapy, and a growing awareness of how pets positively impact mental and physical health. Veterinary clinical trials benefit pet ownership by providing access to advanced treatments and improving veterinary care, which leads to better health outcomes for animals. These trials also help in developing safer and more effective treatments. For instance, a June 2024 report from The People's Dispensary for Sick Animals, a UK-based veterinary charity, projected that the number of pet dogs in the UK will reach approximately 10.6 million by 2024, up from 9.6 million in 2021. This increase in pet ownership is driving the growth of the veterinary clinical trials market.

Companies in the veterinary clinical trials market are concentrating on developing new anti-aging drugs to enhance pet longevity and overall health. Novel anti-aging drugs are innovative medications designed to slow down or reverse the aging process, thereby improving the health and vitality of aging animals. For example, in February 2024, Loyal, a US-based veterinary company, launched a clinical trial for a new anti-aging drug called LOY-002, aimed at extending the healthy lifespan of senior dogs. This chewable pill, intended for most older dogs (except the smallest breeds), is being tested in the STAY study, which plans to recruit over 1,000 dogs aged 10 and older from more than 50 veterinary clinics across the United States. The main goal of LOY-002 is to improve metabolic health, potentially delaying age-related diseases and enhancing the overall quality of life for aging dogs.

In September 2024, Boehringer Ingelheim Group, a Germany-based pharmaceutical company, acquired Saiba Animal Health AG for an undisclosed amount. This acquisition strengthens Boehringer Ingelheim's animal health research and development efforts, particularly in the growing pet therapeutics sector, by integrating an innovative technology platform from Saiba Animal Health AG into its research and development portfolio. Saiba Animal Health AG, a Switzerland-based biotechnology research company, focuses on creating new therapeutic medicines for chronic diseases in pets.

Major companies operating in the veterinary clinical trials market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Laboratory Corporation of America Holdings, Zoetis Inc., Elanco Animal Health Incorporated, Charles River Laboratories International Inc., IDEXX Laboratories Inc., Ceva Sante Animale, Hill's Pet Nutrition Inc., Ethos Veterinary Health LLC, Orion Corporation, Dechra Pharmaceuticals plc, The Schwarzman Animal Medical Center, Argenta Holdco Limited, Morris Animal Foundation, Vaxine Pty Ltd, Bioagile Therapeutics Pvt. Ltd., VetStem Inc., VetDC, Vivesto AB, OCRvet, Vetbiolix, Clinvet International, Ondax Scientific S.l., Veterinary Research Management

North America was the largest region in the veterinary clinical trials market in 2024. The regions covered in the veterinary clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary clinical trials market includes revenues earned by entities by providing services such as study design and protocol development, regulatory compliance and submission, data collection and analysis, and monitoring and quality assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Clinical Trials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary clinical trials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Animal: Livestock Animal; Companion Animal; Other Animals
• 2) By Indications: Oncology; Internal Medicine; Orthopedics; Cardiology; Neurology; Ophthalmology; Dermatology; Other Indications
• 3) By Intervention: Medicines; Medical Devices; Other Interventions
• 4) By End-Users: Academics And Research Centers; Pharmaceutical And Biopharmaceutical Companies; Other End-Users
• Subsegments:
• 1) By Livestock Animal: Cattle; Sheep; Goats; Swine; Poultry
• 2) By Companion Animal: Dogs; Cats; Horses; Rabbits; Ferrets
• 3) By Other Animals: Wildlife; Exotic Pets; Laboratory Animals; Aquatic Animals
• Companies Mentioned: Merck & Co. Inc.; Boehringer Ingelheim International GmbH; Laboratory Corporation of America Holdings; Zoetis Inc.; Elanco Animal Health Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Clinical Trials Market Characteristics

3. Veterinary Clinical Trials Market Trends And Strategies

4. Veterinary Clinical Trials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Clinical Trials Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Clinical Trials Market Growth Rate Analysis
• 5.4. Global Veterinary Clinical Trials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Clinical Trials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Clinical Trials Total Addressable Market (TAM)

6. Veterinary Clinical Trials Market Segmentation

• 6.1. Global Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Livestock Animal
• Companion Animal
• Other Animals
• 6.2. Global Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Internal Medicine
• Orthopedics
• Cardiology
• Neurology
• Ophthalmology
• Dermatology
• Other Indications
• 6.3. Global Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medicines
• Medical Devices
• Other Interventions
• 6.4. Global Veterinary Clinical Trials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academics And Research Centers
• Pharmaceutical And Biopharmaceutical Companies
• Other End-Users
• 6.5. Global Veterinary Clinical Trials Market, Sub-Segmentation Of Livestock Animal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cattle
• Sheep
• Goats
• Swine
• Poultry
• 6.6. Global Veterinary Clinical Trials Market, Sub-Segmentation Of Companion Animal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dogs
• Cats
• Horses
• Rabbits
• Ferrets
• 6.7. Global Veterinary Clinical Trials Market, Sub-Segmentation Of Other Animals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wildlife
• Exotic Pets
• Laboratory Animals
• Aquatic Animals

7. Veterinary Clinical Trials Market Regional And Country Analysis

• 7.1. Global Veterinary Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Clinical Trials Market

• 8.1. Asia-Pacific Veterinary Clinical Trials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Clinical Trials Market

• 9.1. China Veterinary Clinical Trials Market Overview
• 9.2. China Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Clinical Trials Market

• 10.1. India Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Clinical Trials Market

• 11.1. Japan Veterinary Clinical Trials Market Overview
• 11.2. Japan Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Clinical Trials Market

• 12.1. Australia Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Clinical Trials Market

• 13.1. Indonesia Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Clinical Trials Market

• 14.1. South Korea Veterinary Clinical Trials Market Overview
• 14.2. South Korea Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Clinical Trials Market

• 15.1. Western Europe Veterinary Clinical Trials Market Overview
• 15.2. Western Europe Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Clinical Trials Market

• 16.1. UK Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Clinical Trials Market

• 17.1. Germany Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Clinical Trials Market

• 18.1. France Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Clinical Trials Market

• 19.1. Italy Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Clinical Trials Market

• 20.1. Spain Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Clinical Trials Market

• 21.1. Eastern Europe Veterinary Clinical Trials Market Overview
• 21.2. Eastern Europe Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Clinical Trials Market

• 22.1. Russia Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Clinical Trials Market

• 23.1. North America Veterinary Clinical Trials Market Overview
• 23.2. North America Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Clinical Trials Market

• 24.1. USA Veterinary Clinical Trials Market Overview
• 24.2. USA Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Clinical Trials Market

• 25.1. Canada Veterinary Clinical Trials Market Overview
• 25.2. Canada Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Clinical Trials Market

• 26.1. South America Veterinary Clinical Trials Market Overview
• 26.2. South America Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Clinical Trials Market

• 27.1. Brazil Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Clinical Trials Market

• 28.1. Middle East Veterinary Clinical Trials Market Overview
• 28.2. Middle East Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Clinical Trials Market

• 29.1. Africa Veterinary Clinical Trials Market Overview
• 29.2. Africa Veterinary Clinical Trials Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Clinical Trials Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Clinical Trials Market, Segmentation By Intervention, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Clinical Trials Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Clinical Trials Market Competitive Landscape
• 30.2. Veterinary Clinical Trials Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Clinical Trials Market Other Major And Innovative Companies

• 31.1. Charles River Laboratories International Inc.
• 31.2. IDEXX Laboratories Inc.
• 31.3. Ceva Sante Animale
• 31.4. Hill's Pet Nutrition Inc.
• 31.5. Ethos Veterinary Health LLC
• 31.6. Orion Corporation
• 31.7. Dechra Pharmaceuticals plc
• 31.8. The Schwarzman Animal Medical Center
• 31.9. Argenta Holdco Limited
• 31.10. Morris Animal Foundation
• 31.11. Vaxine Pty Ltd
• 31.12. Bioagile Therapeutics Pvt. Ltd.
• 31.13. VetStem Inc.
• 31.14. VetDC
• 31.15. Vivesto AB

32. Global Veterinary Clinical Trials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Clinical Trials Market

34. Recent Developments In The Veterinary Clinical Trials Market

35. Veterinary Clinical Trials Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Clinical Trials Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Clinical Trials Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Clinical Trials Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33613_Veterinary_Clinical_Trials_GMR_2025